drugset / Trial / NCT04634669
Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)
NaSingle-groupOpen-labelTreatment
Summary
This study is a multi-center, open-label trial to evaluate the long-term safety and efficacy of AXS-05 in subjects with major depressive disorder with prior treatment failures
Timeline
- Start
- 2020-09-23
- Primary completion
- 2022-02-18
- Completion
- 2022-03-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 105 mg | — |
| Subject | Dextromethorphan | Unknown | 45 mg | — |